We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Stryker to Acquire Muka Metal in Cash Transaction

By HospiMedica International staff writers
Posted on 27 Jul 2015
Stryker Corporation (Kalamazoo, MI, USA) has announced a definitive agreement to acquire Muka Metal (Kayseri, Turkey). More...


Stryker and Muka Metal, a leading manufacturer and marketer of hospital beds, stretchers, and related patient room furniture and accessories, have maintained a business relationship under a distribution agreement for Muka products in Latin America since 2012. The acquisition will expand Stryker’s global presence in key markets, and especially Turkey, with a product portfolio that complements and enhances the company’s current offerings. Financial details were not disclosed.

Established in 1966, Muka Metal is active in several fields, ranging from office furniture to household electrical appliances. The company began manufacturing electric hospital beds in 2004, and since then has expanded its hospital line to stretchers, patient handling equipment, and furniture. Muka Metal is among the top ten companies in the world in its field, exporting to 60 countries in Africa, the Middle East, Asia, Latin America, and Europe.

“The acquisition of Muka aligns with our strategy to expand our global presence through existing channels with an established and trusted brand,” said Timothy J. Scannell, group president of MedSurg and Neurotechnology at Stryker. “This acquisition will bolster Stryker Medical's bed and stretcher offerings, and is a compelling opportunity to drive growth in Turkey and other regions around the world.”

Stryker has been following an acquisition-driven strategy to boost growth over the last three years, resulting in a total of ten targeted deals that have greatly expanded its product portfolio. Most of the acquisitions provided product lines that are complementary to Stryker’s existing product line, much similar to the Muka deal. The company recently stated that mergers and acquisitions are its top priority for the USD 2.59 billion in ready cash on its balance sheet, with small or mid-sized deals more likely than a blockbuster like the much-speculated-upon possibility of a merger with rival Smith & Nephew (London, United Kingdom).

Related Links:

Stryker Corporation
Muka Metal
Smith & Nephew



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammography System (Analog)
MAM VENUS
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.